|A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection|
PA Selwyn, D Hartel, VA Lewis, EE Schoenbaum, SH Vermund, RS Klein, ...
New England journal of medicine 320 (9), 545-550, 1989
|CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review|
DS Stein, JA Korvick, SH Vermund
Journal of Infectious Diseases 165 (2), 352-363, 1992
|Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors|
SA Ali, RMJ Donahue, H Qureshi, SH Vermund
International journal of infectious diseases 13 (1), 9-19, 2009
|Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa|
ÜS Fideli, SA Allen, R Musonda, S Trask, BH Hahn, H Weiss, J Mulenga, ...
AIDS research and human retroviruses 17 (10), 901-910, 2001
|Depressive symptoms as predictors of medical outcomes in HIV infection|
CG Lyketsos, DR Hoover, M Guccione, W Senterfitt, MA Dew, J Wesch, ...
Jama 270 (21), 2563-2567, 1993
|Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors|
RD Burk, P Kelly, J Feldman, J Bromberg, SH Vermund, JA Dehovitz, ...
Sexually transmitted diseases 23 (4), 333-341, 1996
|High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection|
SH Vermund, KF Kelley, RS Klein, AR Feingold, K Schreiber, G Munk, ...
American journal of obstetrics and gynecology 165 (2), 392-400, 1991
|Combination HIV prevention: significance, challenges, and opportunities|
AE Kurth, C Celum, JM Baeten, SH Vermund, JN Wasserheit
Current Hiv/aids Reports 8 (1), 62-72, 2011
|The effects on survival of early treatment of human immunodeficiency virus infection|
NMH Graham, SL Zeger, LP Park, SH Vermund, R Detels, CR Rinaldo, ...
New England Journal of Medicine 326 (16), 1037-1042, 1992
|Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines|
RI Connor, BTM Korber, BS Graham, BH Hahn, DD Ho, BD Walker, ...
Journal of virology 72 (2), 1552-1576, 1998
|Vaginal douching: evidence for risks or benefits to women’s health|
JL Martino, SH Vermund
Epidemiologic reviews 24 (2), 109-124, 2002
|Genital papillomavirus infection and cervical dysplasia—opportunistic complications of HIV infection|
M Laga, JP Icenogle, R Marsella, AT Manoka, N Nzila, RW Ryder, ...
International journal of cancer 50 (1), 45-48, 1992
|Human papillomavirus infection and other risk factors for cervical neoplasia: a case‐control study|
EAB Morrison, GYF Ho, SH Vermund, GL Goldberg, AS Kadish, KF Kelley, ...
International Journal of Cancer 49 (1), 6-13, 1991
|A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus|
EM Stringer, C Kaseba, J Levy, M Sinkala, RL Goldenberg, BH Chi, ...
American journal of obstetrics and gynecology 197 (2), 144. e1-144. e8, 2007
|Mode of Delivery and Other Maternal Factors Influence the Acquisition of Streptococcus mutans in Infants|
Y Li, PW Caufield, AP Dasanayake, HW Wiener, SH Vermund
Journal of dental research 84 (9), 806-811, 2005
|Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus.|
AR Feingold, SH Vermund, RD Burk, KF Kelley, LK Schrager, K Schreiber, ...
Journal of Acquired Immune Deficiency Syndromes 3 (9), 896-903, 1990
|Risk of HIV/AIDS in China: subpopulations of special importance|
ZH Qian, SH Vermund, N Wang
Sexually transmitted infections 81 (6), 442-447, 2005
|Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985–1991|
A Muñoz, LK Schrager, H Bacellar, I Speizer, SH Vermund, R Detels, ...
American journal of epidemiology 137 (4), 423-438, 1993
|Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?|
L Kuhn, P Kasonde, M Sinkala, C Kankasa, K Semrau, N Scott, WY Tsai, ...
Clinical Infectious Diseases 41 (11), 1654-1661, 2005
|Effect of treating co-infections on HIV-1 viral load: a systematic review|
K Modjarrad, SH Vermund
The Lancet infectious diseases 10 (7), 455-463, 2010